Literature DB >> 22870461

Is remission a more realistic goal in psoriatic arthritis?

Tajvur P Saber1, Ursula Fearon, Douglas J Veale.   

Abstract

Entities:  

Year:  2011        PMID： 22870461      PMCID： PMC3383536          DOI： 10.1177/1759720X10389847

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN： 1759-720X            Impact factor:   5.346


× No keyword cloud information.
  37 in total

1.  Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

Authors:  Christian E Antoni; Arthur Kavanaugh; Bruce Kirkham; Zuhre Tutuncu; Gerd R Burmester; Udo Schneider; Daniel E Furst; Jerry Molitor; Edward Keystone; Dafna Gladman; Bernhard Manger; Siegfried Wassenberg; Ralf Weier; Daniel J Wallace; Michael H Weisman; Joachim R Kalden; Josef Smolen
Journal:  Arthritis Rheum       Date:  2005-04

2.  Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis.

Authors:  J Husted; D D Gladman; J A Long; V T Farewell
Journal:  J Rheumatol       Date:  1996-11       Impact factor: 4.666

3.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2005-11

Review 4.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

5.  The Disease Activity Score and the EULAR response criteria.

Authors:  J Fransen; P L C M van Riel
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis.

Authors:  R J Reece; J D Canete; W J Parsons; P Emery; D J Veale
Journal:  Arthritis Rheum       Date:  1999-07

8.  Infliximab in active early rheumatoid arthritis.

Authors:  F C Breedveld; P Emery; E Keystone; K Patel; D E Furst; J R Kalden; E W St Clair; M Weisman; J Smolen; P E Lipsky; R N Maini
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

9.  Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.

Authors:  A M van Gestel; C J Haagsma; P L van Riel
Journal:  Arthritis Rheum       Date:  1998-10

10.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.